107 related articles for article (PubMed ID: 9724383)
1. Early detection of melanoma metastases with radioiodinated methylene blue.
Link EM; Blower PJ; Costa DC; Lane DM; Lui D; Brown RS; Ell PJ; Spittle MF
Eur J Nucl Med; 1998 Sep; 25(9):1322-9. PubMed ID: 9724383
[TBL] [Abstract][Full Text] [Related]
2. Targeting melanoma with 211At/131I-methylene blue: preclinical and clinical experience.
Link EM
Hybridoma; 1999 Feb; 18(1):77-82. PubMed ID: 10211792
[TBL] [Abstract][Full Text] [Related]
3. Targeting disseminated melanoma with radiolabelled methylene blue: Comparative bio-distribution studies in man and animals.
Link EM; Costa DC; Lui D; Ell PJ; Blower PJ; Spittle MF
Acta Oncol; 1996; 35(3):331-41. PubMed ID: 8679265
[TBL] [Abstract][Full Text] [Related]
4. [211At]methylene blue for targeted radiotherapy of human melanoma xenografts: dose fractionation in the treatment of cutaneous tumours.
Link EM; Carpenter RN; Hansen G
Eur J Cancer; 1996 Jun; 32A(7):1240-7. PubMed ID: 8758260
[TBL] [Abstract][Full Text] [Related]
5. Scintigraphic detection of melanoma metastases with a radiolabeled benzamide ([iodine-123]-(S)-IBZM).
Maffioli L; Mascheroni L; Mongioj V; Gasparini M; Baldini MT; Seregni E; Castellani MR; Cascinelli N; Buraggi GL
J Nucl Med; 1994 Nov; 35(11):1741-7. PubMed ID: 7965150
[TBL] [Abstract][Full Text] [Related]
6. Radioiodinated methylene blue for diagnosing early melanoma metastases.
Link EM; Costa DC; Lane D; Blower PJ; Spittle MF
Lancet; 1996 Sep; 348(9029):753. PubMed ID: 8806307
[No Abstract] [Full Text] [Related]
7. Radioiodinated methylene blue--a promising agent for melanoma scintigraphy: labelling, stability and in vitro uptake by melanoma cells.
Sobal G; Rodrigues M; Sinzinger H
Anticancer Res; 2008; 28(6A):3691-6. PubMed ID: 19189650
[TBL] [Abstract][Full Text] [Related]
8. Differential accumulation of iodine-123-iodobenzamide in melanotic and amelanotic melanoma metastases in vivo.
Larisch R; Schulte KW; Vosberg H; Ruzicka T; Müller-Gärtner HW
J Nucl Med; 1998 Jun; 39(6):996-1001. PubMed ID: 9627332
[TBL] [Abstract][Full Text] [Related]
9. (123)I-BZA2 as a melanin-targeted radiotracer for the identification of melanoma metastases: results and perspectives of a multicenter phase III clinical trial.
Cachin F; Miot-Noirault E; Gillet B; Isnardi V; Labeille B; Payoux P; Meyer N; Cammilleri S; Gaudy C; Razzouk-Cadet M; Lacour JP; Granel-Brocard F; Tychyj C; Benbouzid F; Grange JD; Baulieu F; Kelly A; Merlin C; Mestas D; Gachon F; Chezal JM; Degoul F; D'Incan M
J Nucl Med; 2014 Jan; 55(1):15-22. PubMed ID: 24263087
[TBL] [Abstract][Full Text] [Related]
10. Uptake and therapeutic effectiveness of 125I- and 211At-methylene blue for pigmented melanoma in an animal model system.
Link EM; Brown I; Carpenter RN; Mitchell JS
Cancer Res; 1989 Aug; 49(15):4332-7. PubMed ID: 2743321
[TBL] [Abstract][Full Text] [Related]
11. 211At-methylene blue for targeted radiotherapy of disseminated melanoma: microscopic analysis of tumour versus normal tissue damage.
Link EM; Michalowski AS; Rösch F
Eur J Cancer; 1996 Oct; 32A(11):1986-94. PubMed ID: 8943686
[TBL] [Abstract][Full Text] [Related]
12. 211At-methylene blue in targeted radiotherapy of disseminated melanoma.
Link EM; Michalowski AS; Rösch F
Pigment Cell Res; 1994 Oct; 7(5):358-62. PubMed ID: 7886009
[TBL] [Abstract][Full Text] [Related]
13. Uptake of [131I]thiouracil in tumours of patients with disseminated malignant melanoma. A pilot study.
Olander K; Larsson BS; Ringborg U; Schnell PO
Melanoma Res; 1992; 1(5-6):391-5. PubMed ID: 1422195
[TBL] [Abstract][Full Text] [Related]
14. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
15. Radioiodine-labelled alpha-methyl-tyrosine in malignant melanoma: cell culture studies and results in patients.
Böni R; Steinert H; Huch Böni R; Von Schulthess GK; Meyer J; Dummer R; Burg G; Westera G
Br J Dermatol; 1997 Jul; 137(1):96-100. PubMed ID: 9274632
[TBL] [Abstract][Full Text] [Related]
16. 123I-N-(2-diethylaminoethyl)-2-iodobenzamide: a potential imaging agent for cutaneous melanoma staging.
Moins N; D'Incan M; Bonafous J; Bacin F; Labarre P; Moreau MF; Mestas D; Noirault E; Chossat F; Berthommier E; Papon J; Bayle M; Souteyrand P; Madelmont JC; Veyre A
Eur J Nucl Med Mol Imaging; 2002 Nov; 29(11):1478-84. PubMed ID: 12397467
[TBL] [Abstract][Full Text] [Related]
17. 211At-methylene blue for targeted radiotherapy of human melanoma xenografts: treatment of cutaneous tumors and lymph node metastases.
Link EM; Carpenter RN
Cancer Res; 1992 Aug; 52(16):4385-90. PubMed ID: 1643635
[TBL] [Abstract][Full Text] [Related]
18. [67Ga-citrate SPECT imaging of the isolated right ventricle heart metastatic malignant melanoma in a patient with chest pain].
Dolezal J; Vizd'a J; Klzo L
Vnitr Lek; 2008 Sep; 54(9):862-5. PubMed ID: 18924347
[TBL] [Abstract][Full Text] [Related]
19. Detection of melanoma metastases with thallium-201 scintigraphy.
Rettenbacher L; Koller J; Kässmann H; Galvan G
J Nucl Med; 1998 May; 39(5):798-802. PubMed ID: 9591578
[TBL] [Abstract][Full Text] [Related]
20. The role of technetium-99m sestamibi single photon emission tomography in the follow-up of malignant melanoma and the detection of lymph node metastases.
Soler C; Perrot JL; Thiffet O; Beauchesne P; Lanthier K; Boucheron S; Dubois F; Cambazard F
Eur J Nucl Med; 1997 Dec; 24(12):1522-5. PubMed ID: 9391188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
